BACKGROUND AND AIM: Creating potential clinical markers for risk assessment in patients with COVID-19 continues to be an area of interest. In this study, we aimed to evaluate whether serum albumin level and thrombocyte/lymphocyte ratio are related to the severity of the disease. MATERIALS AND METHODS: The patients were divided into two groups according to the severity of disease. Demographic data, serum albumin value, lymphocyte count, TLO-1 values (thrombocyte/lymphocyte ratio-1), the highest thrombocyte count during hospitalization, TLO-2 (thrombocyte/lymphocyte ratio-2) values formed by the highest thrombocyte count, was recorded. RESULTS: There was no statistically significant differences (p> 0.05) in terms of gender, thrombocyte count at the time of admission, and highest thrombocyte count during hospital follow-up. There were statistically significant differences in terms of age, comorbidity, lymphocyte value at the time of hospitalization, lymphocyte count during hospital follow-up, TLO I, TLO II, and serum albumin values between the groups. In the ICU group were found to be older, had higher rates of comorbidity, lower lymphocyte values, higher TLO I- II, and lower serum albumin levels (P <0.05) Conclusions: TLO-2 ratio above 260 and lymphocyte level below 1x 103cells/uL, would be a predictor of further intensive care unit need.
Could serum albumin value and thrombocyte / lymphocyte ratio be an important prognostic factor in determining the severity of COVID 19?